China BioPharma

China has made biotechnology and healthcare a major funding prerogative in its long term R&D strategy. Demographic analysis shows that China will have more than 300 million people over the age of 60 by 2030.  To cope with this tremendous challenge to its healthcare system, China is investing in a host of new initiatives designed to accelerate delivery of cost effective solutions in areas ranging from infectious disease to advanced imaging, sensing and diagnostic devices, to agriculture and food security, traditional Chinese medicine as a therapeutic platform, and importantly, massive drug discovery innovation. A focus shift from generic drugs and CRO manufacturing to early stage R&D and innovation is transforming China into a global pharmaceutical powerhouse. Companies seeking to succeed in China must:
  • Understand government funding guidelines and regulations as China seeks to accelerate development of its healthcare industry to meet its emerging demographic needs
  • Follow the funding to find the emerging innovation clusters, labs, centers of excellence, and companies, as China invests for the long term
  • Regard China as a “one country-two markets” opportunity to accurately gauge opportunities
  • Develop a dynamic and aggressive partnering strategy to tap innovation, navigate the regulatory maze, and build a robust go to market capability

Sample topics covered by Lux Research:

Technologies:

  • Stem cells
  • In vitro and molecular diagnostics
  • Medical devices
  • Genomics
  • Proteomics
  • Traditional Chinese Medicine
  • Sensors
  • Synthetic Biology
  • Marine and Agricultural biotechnology

Applications:

  • Discovery platforms
  • Companion Diagnostics
  • Translational Medicine
  • Agriculture
  • Genetically modified organisms
  • Molecular targeting
  • Diagnostics
  • Sensors
  • Devices
  • Regeneration
  • Transplantation
  • Vaccines
  • Advanced imaging

Companies:

  • Changchun Institute of Applied Chemistry
  • Broda
  • Anti-Cancer Solution Ltd. (ACSL)
  • Lotus Innovative Therapeutics
  • Dirui
  • Tigermed
  • Sirnaomics
  • Mindray
  • BGI Shenzhen
  • View a sample Company Profile